1.
|
Phase: Phase IV Type: Diagnostic, Supportive care, Treatment Status: Active Age: 40 to 65 Sponsor: Other Protocol IDs: 2004/949, NCT00111241
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: STARS-Pilot (05/55 Graham), NCT00126360
|
|
3.
|
Phase: Phase IV Type: Treatment Status: Active Age: Postmenopausal to 65 Sponsor: Pharmaceutical / Industry Protocol IDs: 1033MX/001, NCT00262535
|
|
4.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: not specified Sponsor: Other Protocol IDs: N07MAN, Eudract 2007-007030-20, NCT00684216
|
|
5.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 65 and over Sponsor: Other Protocol IDs: 0120070323, NCT00698971
|
|
6.
|
Phase: Phase III Type: Treatment Status: Active Age: 40 to 70 Sponsor: Other Protocol IDs: CRUK-IBIS-II-DCIS, EU-20226, BIG-5-02, NCT00072462, IBCSG-31-03-DCIS, ISRCTN31488319
|
|
7.
|
Phase: Phase III Type: Treatment Status: Active Age: Postmenopausal Sponsor: NCI Protocol IDs: SWOG-S0226, CAN-NCIC-MAC7, S0226, NCT00075764
|
|
8.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: Postmenopausal Sponsor: Other Protocol IDs: ALCC 04.02, NCT00122356
|
|
9.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A5991048, NCT00143390
|
|
10.
|
Phase: Phase III Type: Treatment Status: Active Age: Any age Sponsor: Other Protocol IDs: ICR-CTSU-SOFEA, EU-20531, SSA-04Q200635, ISRCTN44195747, MREC-03677, EUDRACT-2004-000093-30, NCT00253422
|
|
11.
|
Phase: Phase III Type: Treatment Status: Active Age: 21 to 65 Sponsor: Other Protocol IDs: TMH/153/2004, NCT00193778
|
|
12.
|
Phase: Phase III Type: Treatment Status: Active Age: Postmenopausal Sponsor: NCI Protocol IDs: ACOSOG-Z1031, CALGB-ACOSOG-Z1031, SDC1, NCT00265759
|
|
13.
|
Phase: Phase III Type: Treatment Status: Active Age: 80 and under Sponsor: Pharmaceutical / Industry Protocol IDs: 1033AU/0003, ABCSG 16, D5392L00016, SALSA, NCT00295620
|
|
14.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: NCI Protocol IDs: ECOG-PACCT-1, SWOG-ECOG-PACCT-1, CALGB-ECOG-PACCT-1, NCCTG-ECOG-PACCT-1, NSABP-ECOG-PACCT-1, ACOSOG-ECOG-PACCT-1, CAN-NCIC-MAC12, PACCT-1, NCT00310180, TAILORx
|
|
15.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D5392NL0003, EUDRAct No: 2005-006167-31, NCT00301457
|
|
16.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: GIM-3-FATA, GIM3-FATA, EUDRACT-2006-004018-42, EU-20764, NCT00541086
|
|
17.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: GEICAM/2006-10, NCT00543127
|
|
18.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 and over Sponsor: Pharmaceutical / Industry Protocol IDs: D539BC00001, NCT00605267
|
|
19.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: GIM-GIM8-OVER, GIM8-OVER, EUDRACT-2007-006031-30, EU-20853, GSK-GIM-GIM8-OVER, ZENECA-GIM-GIM8-OVER, OVER, NCT00688194
|
|
20.
|
Phase: Phase III Type: Treatment Status: Active Age: Under 70 Sponsor: Other, Pharmaceutical / Industry Protocol IDs: INCA-MNEMOSYNE, MNEMOSYNE, 2007-12, RECF0899, EUDRACT-2008-003620-32, NCT00893061
|
|
21.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: TROG 08.06, NCT00887380
|
|
22.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: GUMC-2004-251, 6584, NCI-6584, NCT00217399
|
|
23.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UCI 03-16, NCT00256217
|
|
24.
|
Phase: Phase II Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: JBCRN-06, UMIN000000610, NCT00437359
|
|
25.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: BRSADJ0008, 97923, BRSADJ0008, NCT00481845, NCT00481845
|